Newsroom

MEDIA

FIRSTWORD PHARMA

December 18, 2025

For its next AI deal, Boehringer turns to Galux for precision protein design

Read More

NEWS

December 17, 2025

Galux Announces Research Agreement with Boehringer Ingelheim to Advance AI-Driven Protein Design

Read More

NEWS

December 11, 2025

Galux and Seoul National University Develop ‘T-SCAPE,’ an AI for Predicting Immunogenicity of Drug Candidates

Read More

NEWS

December 2, 2025

Galux and Celltrion Enter Strategic Partnership to Co-Develop Next-Generation Multispecific Antibodies for Autoimmune Diseases

Read More

INTERVIEW

THE BIO

December 1, 2025

Galux claims ‘one-day antibody design’ as it enters the global top-three AI race

Read More

NEWS

November 26, 2025

Galux Achieves Breakthrough by Delivering High-Affinity De Novo Antibodies from Only 50 AI Designs, Marking a New Era in Precision Protein Design

Read More

NEWS

November 14, 2025

Galux and ISU Abxis Sign MOU to Collaborate on AI-Driven Drug Discovery

Read More

NEWS

September 30, 2025

Galux and Woojung Bio Forge Strategic Partnership to Accelerate AI-Driven Therapeutics Development

Read More

NEWS

September 23, 2025

Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets

Read More

MEDIA

THE PHARMACEUTICAL JOURNAL

August 22, 2025

Designed by AI: the future of antibody drugs

Read More

NEWS

June 11, 2025

Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer

Read More

INTERVIEW

KOREATECHDESK

May 26, 2025

Pioneering Precision: How South Korea's Galux is Redefining Antibody Discovery with AI

Read More